0       0

NACCT 2019


TUE800 - AACT Pre-Symposium: Toxicologist Versus Terrorist: Preparing for the Worst Call - Part 1


Sep 24, 2019 8:00am ‐ Sep 24, 2019 11:45am

Description

Emily Kiernan, DO
**Soman Sarin Novichok**

Learning Objectives:

  1. Intergate knowledge of some recent worldwide events involving nerve agents into your practice.
  2. Compare and contrast the decisions made when identifying and treating patients from nerve agent attacks.
  3. Recite the role a toxicologists can play in a nerve agent attack.


Frank Walter, MD
**Weapons of Opportunity**

Learning Objectives:

  1. Identify and discuss the physical property that many of chemical weapons of opportunity share.
  2. List the relative toxicity of various chemical weapons of opportunity.
  3. Identify and discuss the fundamental therapeutic modality for many chemical weapons of opportunity.

Sean Bryant, MD
Atropine

Learning Objectives:

  1. Recite the pharmacology of atropine.
  2. Discuss atropine utilization in times of terrorism and war.
  3. Compare and contrast the strengths and weaknesses of various alternative antimuscarinic agents when atropine is in short supply.

Steve Bird, MD
2PAM

Learning Objectives:

  1. Describe the basic structure of oximes.
  2. List the limitations to oxime use.
  3. Identify scenarios when oxime use is indicated.

Sue Gorman, PharmD
**Antidote Stockpile**

Learning Objectives:

  1. Describe the ways in which the Strategic National Stockpile may respond to an incident.
  2. Describe the SNS CHEMPACK program.

Annie Arens, MD
Vomiting Agents – Organoarsenic Compounds

Learning Objectives:

  1. Describe the history of the development and use of organoarsenic compounds as chemical warfare agents.
  2. Describe the clinical effects of exposure to organoarsenic compounds.
  3. Recite the proposed mechanism of toxicity of organoarsenic compounds.

Vikhyat Bebarta, MD
Cyanide /H2SCyanide

Learning Objectives:

  1. Determine the clinical effects of Cyanide /H2S poisoning.
  2. Describe the new therapies for cyanide.
  3. Decribe the new therapies or H2S.

**Presentation will not be audio recorded**

Speaker(s):

Disclosures

  • Sean Bryant, MD :

    Off label drugs

  • Vikhyat Bebarta, MD :

    Off label drugs

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content